Delivery Order SPE2DB22D3301-SPE2DB24FY1EH
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $3,581.40. The contract has a period of performance through February 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the...
- Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has been awarded a $4,698.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc., was awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $2,963.80. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and will deliver the pharmaceutical product to the DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,375.77 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184900 - PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $1,215.60 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,597.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,392.48 contract is for the delivery of a pharmaceutical product, PROCTOFOAM-HC 1%-1% FOAM 10GM, to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM pharmaceutical products. The $1,641.20 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,163.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support military treatment programs and facilities. The delivery order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1EHDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., has been awarded a firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a potential value of $1,343.96. The award does not have a set-aside designation. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/21/24 |